None
SEDAR Interim Financial Statements
UDOC · Price
[
{
"companyName": "Unidoc Health Corp.",
"reportingPeriodEnd": "2025-12-31",
"reportStatus": "Unaudited",
"auditorName": null,
"auditorKeyMatters": [],
"balanceSheet": {
"cash": 637805,
"prepaidExpensesAndDeposits": 521497,
"receivables": 323264,
"totalCurrentAssets": 1482566,
"equipment": 90709,
"goodwill": 372750,
"intangibleAssets": 320736,
"rightOfUseAsset": 31896,
"totalAssets": 2298657,
"accountsPayableAndAccruedLiabilities": 1901700,
"loanPayable": 3410,
"leaseLiabilityCurrent": 31000,
"deferredRevenueCurrent": 275631,
"deferredAcquisitionCostsCurrent": 25860,
"totalCurrentLiabilities": 2237601,
"leaseLiabilityNonCurrent": 2768,
"deferredRevenueNonCurrent": 61745,
"deferredAcquisitionCostsNonCurrent": 24381,
"totalLiabilities": 2326495,
"shareCapital": 13819932,
"reserves": 1212208,
"accumulatedOtherComprehensiveLoss": -7685,
"deficit": -15052293,
"totalEquity": -27838,
"totalLiabilitiesAndEquity": 2298657,
"cashPerShare": 0.0081,
"workingCapitalPerShare": -0.0096
},
"incomeStatement": {
"revenue": 697060,
"costOfSales": 383142,
"grossProfit": 313918,
"accretion": 12515,
"advertising": 462235,
"consulting": 991820,
"depreciation": 134709,
"foreignExchangeLoss": -29623,
"interestExpense": 4957,
"generalAndAdministrative": 215775,
"professionalFees": 268709,
"regulatoryAndFilingFees": 45192,
"researchAndDevelopment": 6315,
"salariesAndBenefits": 134670,
"shareBasedCompensation": 0,
"shippingAndDelivery": 11931,
"software": 12695,
"travelAndEntertainment": 125310,
"totalOperatingExpenses": 2397210,
"lossOnFairValueAdjustment": -46348,
"interestIncome": 0,
"netLoss": -2129640,
"exchangeDifferencesOnTranslatingForeignOperations": -7685,
"comprehensiveLoss": -2137325,
"weightedAverageSharesOutstandingBasic": 78750090,
"lossPerShareBasic": -0.03
},
"cashFlowStatement": {
"netLoss": -2129640,
"accretion": 12515,
"depreciation": 134709,
"interestExpense": 545,
"fairValueLoss": 46348,
"foreignExchange": -32471,
"shareBasedCompensation": 0,
"changesInReceivables": -175221,
"changesInPrepaidExpensesAndDeposits": 123754,
"changesInInventory": 0,
"changesInAccountsPayableAndAccruedLiabilities": 164417,
"changesInDeferredRevenue": -121195,
"cashUsedInOperatingActivities": -1976239,
"purchasesOfEquipment": -73391,
"cashUsedInInvestingActivity": -73391,
"cashProceedsFromIssuanceOfCommonShares": 1500000,
"shareIssuanceCosts": -33737,
"cashProceedsFromExerciseOfWarrants": 0,
"cashProceedsFromExerciseOfUnitWarrants": 0,
"cashProceedsFromExerciseOfOptions": 0,
"repaymentOfLoans": -11279,
"leaseLiabilityPayments": -25180,
"interestOnLease": 4412,
"cashProvidedByFinancingActivities": 1434216,
"netChangeInCash": -615414,
"cashBeginning": 1253219,
"cashEnding": 637805,
"interestPaid": 4957,
"interestReceived": 0,
"shareIssuanceCostsIncludedInAccountsPayable": 21301,
"purchasesOfEquipmentIncludedInAccountsPayable": 18461,
"sharesIssuedForVestedRSUs": 0
},
"investmentsAndOtherAssets": [],
"shareStructure": {
"authorizedShares": "Unlimited",
"issuedShares": 86350090,
"classesOfShares": ["Common Shares"],
"warrants": [
{
"number": 2752100,
"exercisePrice": 1.25,
"expiryDate": "2026-10-25"
},
{
"number": 10000000,
"exercisePrice": 0.25,
"expiryDate": "2028-10-27"
}
],
"options": [],
"rightsConvertibleInstruments": "70,000 RSUs vested but not yet issued"
},
"managementCompensation": {
"currency": "CAD",
"periods": [
{
"period": "Nine months ended December 31, 2025",
"components": {
"salary": 327332,
"bonus": 0,
"total": 327332
}
},
{
"period": "Nine months ended December 31, 2024",
"components": {
"salary": 510724,
"bonus": 9286,
"total": 520010
}
}
],
"namedIndividuals": [
{
"name": "Key Management",
"title": "Key Management Personnel",
"period": "Nine months ended December 31, 2025",
"components": {
"salary": 327332,
"bonus": 0,
"total": 327332
}
},
{
"name": "Key Management",
"title": "Key Management Personnel",
"period": "Nine months ended December 31, 2024",
"components": {
"salary": 510724,
"bonus": 9286,
"total": 520010
}
}
],
"otherRelatedPartyTransactions": [
{
"counterparty": "Company controlled by CEO",
"description": "Consulting fees payable",
"amount": 609411,
"period": "December 31, 2025"
},
{
"counterparty": "CEO",
"description": "Expense reimbursements payable",
"amount": 216822,
"period": "December 31, 2025"
},
{
"counterparty": "CFO",
"description": "Expense reimbursements payable",
"amount": 1130,
"period": "December 31, 2025"
},
{
"counterparty": "Director",
"description": "Expense reimbursements payable",
"amount": 105,
"period": "December 31, 2025"
},
{
"counterparty": "CEO",
"description": "Loan payable from personal credit card",
"amount": 3410,
"period": "December 31, 2025"
},
{
"counterparty": "Company controlled by a director",
"description": "Accrued interest on debt settlement agreement",
"amount": 96548,
"period": "December 31, 2025"
},
{
"counterparty": "Companies controlled by CEO and CFO",
"description": "Consulting fees incurred during the period",
"amount": 327332,
"period": "Nine months ended December 31, 2025"
},
{
"counterparty": "Companies controlled by directors",
"description": "Consulting fees incurred during the period",
"amount": 0,
"period": "Nine months ended December 31, 2025"
},
{
"counterparty": "CFO",
"description": "Share-based compensation",
"amount": 0,
"period": "Nine months ended December 31, 2025"
}
]
},
"subsequentEvents": [
{
"eventDate": "2026-01-06",
"description": "Issued 266,400 common shares to settle debt with a company controlled by a director, reducing accounts payable and accrued liabilities by $96,548.",
"impactValue": 96548
}
]
}
]
More from Unidoc Health Corp
Jun 09, 2026 · 07:30